Scott Schliebner, Senior Vice President, Center for Rare Diseases at PRA Health Sciences talks about how amore patient-centred approach is needed to increase par ticipation and access, and how technology may hold the key.
Certain challenges within the drug development landscape merit a dedicatedtask force of experts and capabilities. That’s why we built our collection…
The Center for Rare Diseases
We never forget that rare diseases alter entire lives—and we’re committed to changing that. Every day can be delayed, postponed, or canceled when…